logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Pacira Pharmaceuticals, Inc.


USPTO Granted Patents = 60

% Expired Patents = 8.3


Trademarks = 8

Forward Citations = 736

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal John J Grigsby, Jr (26 out of 27 patents)

silverMedal Kathleen D A Los (26 out of 26 patents)

bronzeMedal Jeffrey S Hall (24 out of 26 patents)

4.  Soroush M Ardekani (21 out of 21 patents)

5.  Louie Daniel Garcia (20 out of 20 patents)

6.  David J Turnbull (16 out of 16 patents)

7.  Stephanie M Kurz (12 out of 12 patents)

8.  Ernest George Schutt (11 out of 67 patents)

9.  Eran Levy (10 out of 11 patents)

10.  Paige N Davis (9 out of 9 patents)

11.  Liangjin Zhu (8 out of 8 patents)

12.  Ronald Warren McGuire (8 out of 8 patents)

13.  Peter Andrew Walters (8 out of 8 patents)

14.  Roy Winston (8 out of 8 patents)

15.  William Joseph Lambert (7 out of 7 patents)


Core Competencies:
Bupivacaine
Liposomal Anesthetic
Dexamethasone
Multivesicular Liposomes
Sustained Release
Microparticle Formulations
Pain Management
Zinc Meloxicam
Synthetic Membrane Vesicles
Post-Operative Pain
Total Knee Arthroplasty
Pediatric Patients

60 patents:

1. 12728095 - Manufacturing of bupivacaine multivesicular liposomes (2026-09-08),
2. 12728094 - Manufacturing of bupivacaine multivesicular liposomes (2026-09-08),
3. 12539274 - Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same (2026-02-03),
4. 12433878 - Uses of bupivacaine multivesicular liposomes as stellate ganglion block (2025-10-07),
5. 12370142 - Manufacturing of bupivacaine multivesicular liposomes (2025-07-29),
6. 12318483 - Manufacturing of bupivacaine multivesicular liposomes (2025-06-03),
7. 12296047 - Manufacturing of bupivacaine multivesicular liposomes (2025-05-13),
8. 12285435 - Multivesicular liposome formulations of dexamethasone (2025-04-29),
9. 12285419 - Bupivacaine multivesicular liposome formulations and uses thereof (2025-04-29),
10. 12280149 - Manufacturing of bupivacaine multivesicular liposomes (2025-04-21),
11. 12251472 - Manufacturing of bupivacaine multivesicular liposomes (2025-03-18),
12. 12251468 - Manufacturing of bupivacaine multivesicular liposomes (2025-03-18),
13. 12246092 - Manufacturing of bupivacaine multivesicular liposomes (2025-03-11),
14. 12226610 - Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions (2025-02-18),
15. 12178909 - Manufacturing of bupivacaine multivesicular liposomes (2024-12-31),
Pacira Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, specializing in innovative liposomal formulations for pain management. The company focuses on developing advanced drug delivery systems, particularly utilizing multivesicular liposomes to enhance the efficacy and safety of anesthetics such as bupivacaine and dexamethasone. Pacira's commitment to improving patient outcomes is evident in its research on sustained release and microparticle formulations, addressing critical needs in postoperative pain management.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Pacira Pharmaceuticals, Inc.
60 Patents

#104 in San Diego, CA

#1,401 in California

#5,991 in US

#12,077 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Pacira Pharmaceuticals, Inc.

Forward Citations = 736

36 inventors:

goldMedal John J Grigsby, Jr (26 out of 27 patents)

silverMedal Kathleen D A Los (26 out of 26 patents)

bronzeMedal Jeffrey S Hall (24 out of 26 patents)

4.  Soroush M Ardekani (21 out of 21 patents)

5.  Louie Daniel Garcia (20 out of 20 patents)

Please report any incorrect information to [email protected]
Loading…